Earnings release
Page 1
QUANTINUUM Quantinuum Reports Second Quarter 2026 Results August 11 , 2026 Second - Quarter Revenue Grew 279 % Year - Over - Year ; Increased FY2026 Outlook Demonstrated Near Five - Nines Logical Fidelity on Helios , Extending Leadership in Fault Tolerance Announced Industry - First Partnership with Oracle to Deploy Helios as an Oracle Cloud Infrastructure ( OCI ) Service Strengthened Supply Chain Through Strategic Collaboration with Major Global Electronics Manufacturer BROOMFIELD , Colo . , Aug. 11 , 2026 / PRNewswire / - Quantinuum Inc. ( Nasdaq : QNT ) ( the " Company " ) , a leading quantum computing company , today announced financial results for the second quarter ended June 30 , 2026 . D QUANTINUUM " Our second quarter performance demonstrated strong execution against our strategy . We delivered critical R & D breakthroughs to advance our platform roadmap and enhance our competitive position , strengthened our supply chain and manufacturing capabilities , and increased our developer ecosystem engagement , " said Rajeeb Hazra , President and CEO of Quantinuum . " As a result , we are seeing accelerating commercial momentum for the business , reflected in the second quarter results and the improved full - year outlook . With over $ 2 billion in cash , we have the capability to invest to accelerate our business plans , while maintaining a disciplined approach to capital allocation to ensure sustainable long - term growth and profitability . " Second Quarter 2026 Financial Highlights • Completed industry's first traditional initial public offering , raising $ 1.7 billion in gross proceeds • Revenue was $ 8 million , + 279 % year - over - year , versus $ 2 million in the prior - year period • GAAP gross margin was ( 64.4 % ) , up 27 percentage points versus the prior - year period Adjusted gross margin was 62 % , down 60 basis points versus the prior - year period • GAAP net loss was $ 597 million , compared with a net loss of $ 57 million in the prior - year period • Adjusted EBITDA loss was $ 68 million , compared with a loss of $ 43 million in the prior - year period • GAAP net loss per share attributable to Class A common stockholders was $ 1.93 Adjusted net loss per share was $ 0.28 • Cash & cash equivalents , and short - term investments were $ 2.1 billion as of June 30 , 2026 Adjusted EBITDA , Adjusted Gross Margin and Adjusted net loss per share are non - GAAP financial measures defined under " Non - GAAP Financial Measures . " For a reconciliation of these non - GAAP financial measures to the most directly comparable GAAP financial measures , refer to the Appendix tables at the end of this press release . Second Quarter and Recent Business Highlights Commercial Highlights • Announced an industry - first strategic partnership with Oracle to deploy Helios on Oracle Cloud Infrastructure's ( OCI ) AI data center to enable hybrid quantum - Al workloads as an OCI service . By operating on - premises within OCI's infrastructure , Helios is anticipated to be able to integrate seamlessly with existing OCI compute , networking , storage , identity , and data services under the same governance and access controls customers already use . • Announced strategic collaboration with HPE to establish a framework for combining quantum computing with HPC and Al environments and engage enterprise customers on hybrid quantum - classical solutions for high - value scientific and industrial use cases .
Page 2
R&D Milestones Product Technology and Supply Chain Demonstrated industry-leading near five-nines logical fidelity on Helios, with a novel QEC code family, reinforcing Quantinuum's leadership in fault tolerance. Progressing towards the launch of Sol in 2027, with Sol's trap chip back from fabrication and advancing through product validation. Apollo remains on schedule for 2029, with significant progress made across key architectural subsystems through prototyping. Signed a new joint development agreement with a leading global electronics manufacturer to co-develop the infrastructure, systems engineering, and manufacturing capabilities required for future generations of quantum computers. Entered into a letter of intent with the U.S. Department of Commerce's CHIPS R&D Office to strengthen onshore supply chains and accelerate U.S. leadership in trapped-ion quantum computing. Ecosystem Accelerated Nexus adoption, with 180 organizations now using the cloud-based developer platform to build new quantum applications. Launched Guppy Playpond, a frictionless web-based environment set up for developers to learn writing and testing code in Guppy, to increase adoption of this next-generation quantum programming language. Expanded the Quantinuum Startup Partner Program with Qedma, integrating its error suppression and mitigation software into Quantinuum's Nexus platform, giving enterprise and scientific users an additional optimization layer that can improve accuracy for large, complex workloads. Application Research Invented a new parallel quantum phase-estimation algorithm for faster and more precise determination of molecular properties, with broad applications including pharmaceuticals, life-sciences, and energy. Demonstrated, with NVIDIA and a Fortune 100 pharma company, how AI-driven quantum simulation can potentially enhance molecular property characterization in pharmaceutical applications. Simulated complex magnetic materials with accuracy beyond the practical capabilities of the most advanced classical computers, with applicability to improving maglev and MRI systems. Financial Outlook Establishing first formal guidance as a public company, with 2026 revenue expected to be in the range of $28 to $32 million. Second Quarter 2026 Conference Call Quantinuum will host a conference call at 5 PM Eastern time on Tuesday, August 11, 2026, to discuss its results for the second quarter ended June 30, 2026, and provide a business update. The call will be available live via webcast here. An archived replay of the webcast will be made available on the Quantinuum Investor Relations website following the call and will remain available for one year. Non-GAAP Financial Measures To supplement Quantinuum's condensed consolidated financial statements presented in accordance with U.S. generally accepted accounting principles ("GAAP"), the Company uses the following non-GAAP financial measures presented in this release: Adjusted Gross Profit, Adjusted Gross Margin, Adjusted Net Loss, fully distributed, Adjusted EBITDA, and Adjusted Net Loss Per Share, fully distributed. Adjusted Gross Profit starts with GAAP gross profit and adds back equity compensation and related employer taxes attributable to cost of revenue and depreciation and amortization attributable to cost of revenue. Adjusted Gross Margin is calculated as Adjusted Gross Profit divided by revenue, net. Adjusted Net Loss, fully distributed starts with GAAP net loss on an as-converted basis, adds back GAAP income tax expense, adjusts for equity compensation and related employer taxes, costs of the initial public offering and the transition to public company reporting, the change in fair value of liability-classified warrants, and loss on disposal and write down of assets, and then applies an assumed statutory tax rate to the resulting adjusted pre-tax loss. No tax benefit is recognized in respect of losses subject to a full valuation allowance, and accordingly no tax benefit is reflected in the periods presented. Adjusted EBITDA starts with Adjusted Net Loss, fully distributed, and further excludes interest income, net, depreciation, and amortization of acquired intangibles. Adjusted Net Loss Per Share, fully distributed is calculated as Adjusted Net Loss, fully distributed, divided by adjusted shares,
Page 3
fully distributed, basic and diluted, comprising weighted-average Class A common shares outstanding and Common Units of Quantinuum Holdings. Management believes these measures provide investors with additional information useful in evaluating the Company's operating performance and trends across periods. Quantinuum's results include large non-cash charges that do not reflect the cost of operating the business in the period, principally stock-based compensation recognized on completion of the Reorganization and remeasurement of liability-classified warrants. Both are driven by accounting triggers and external inputs rather than operating activity. As an early commercial-stage business, Quantinuum's period-to-period results also are affected by the timing of individual contracts. Measures that isolate underlying operating performance from non-cash and transition items help investors assess trends across periods. Quantinuum's Up-C structure means that GAAP net loss attributable to Quantinuum Inc. reflects only the Class A share of the economics. Presenting adjusted results on an as-converted, fully distributed basis describes the whole economic enterprise, which is how management assesses performance and how the business is managed. Management uses these measures for internal planning and forecasting, evaluating operating performance, and preparing budgets. These non-GAAP financial measures are supplemental and are not prepared in accordance with GAAP. They are not intended to be considered in isolation or as a substitute for the most directly comparable financial information prepared in accordance with GAAP. Quantinuum's non-GAAP measures may differ from similarly titled measures used by other companies and, therefore, may not be comparable. Investors should review the reconciliations and should not rely on any single financial measure to evaluate the Company's business. Each non-GAAP financial measure is reconciled to its most directly comparable GAAP financial measure in the tables at the end of this release. About Quantinuum Quantinuum is a leading quantum computing company offering a full-stack platform designed to make quantum computing deployable in real-world environments. The company has commercially deployed multiple generations of trapped-ion based quantum systems built on the well-established QCCD architecture, which it has implemented with novel designs and capabilities to achieve the industry's highest accuracy levels based on average two-qubit gate fidelity. [1] Quantinuum has active engagements with market leaders across pharmaceuticals, material science, financial services, and government and industrial markets, as well as academic and research institutions globally. The company has a global workforce of approximately 800 employees, including top scientists and researchers. Over 70% of its technology team holds PhDs or Master's degrees. Quantinuum's headquarters is in Broomfield, Colorado, with additional facilities across the United States, United Kingdom, Germany, Japan, Qatar, and Singapore. For more information, please visit www.quantinuum.com. Availability of Information on Quantinuum's Website Investors and others should note that Quantinuum routinely announces material information to investors and the marketplace using SEC filings, press releases, public conference calls, webcasts and the Quantinuum Investor Relations website. While not all of the information that the Company posts to the Quantinuum Investor Relations website is of a material nature, some information could be deemed to be material. Accordingly, the Company encourages investors, the media and others interested in Quantinuum to review the information that it shares on ir.quantinuum.com. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on the current beliefs and expectations of Quantinuum's management and are subject to significant risks and uncertainties. Actual results may differ materially from those described in the forward-looking statements. Any statements made in this press release that are not statements of historical fact, including statements about our beliefs, expectations and outlook are forward-looking statements. Forward-looking statements include information concerning possible or assumed future results of operations, including our guidance and descriptions of our business plans and strategies. These statements often include words such as "anticipate," "expect," "guidance," "suggest," "plan," "believe," "intend," "estimate," "target," "project," "should," "could," "would," "may," "will," "forecast," "outlook," "potential," "continues," "seeks," "predicts," or the negatives of these words and other similar expressions. Factors that could cause actual results to differ materially from those described in forward-looking statements include, but are not limited to: our ability to develop, commercialize and achieve market acceptance of our quantum computing hardware and software products; the pace of development of the quantum computing industry and the timing of commercial quantum advantage; our ability to attract and retain customers for our quantum computing systems and quantum computing as a service offerings; the risk of technological obsolescence or the emergence of competing quantum computing approaches, including superconducting, photonic, or other modalities; our dependence on key suppliers and manufacturers of specialized components, including those necessary for our trapped-ion quantum systems; our ability to scale production of our quantum computers and related systems; our ability to protect our intellectual property and proprietary technology; the significant research and development costs inherent in developing next-generation quantum computing capabilities; our ability to attract and retain highly skilled scientists, engineers and other personnel in a competitive labor market; changes in government funding, export controls, or regulations affecting quantum technologies; uncertainty regarding the timing and extent of commercial applications; cybersecurity risks and the
Page 4
protection of sensitive customer data; and macroeconomic conditions, geopolitical instability and their potential effects on our business and operations. For additional information on these and other risks that could affect the Company's forward-looking statements, see the Company's risk factors discussed in its filings with the U.S. Securities and Exchange Commission, as such risk factors may be updated from time to time. You should evaluate all forward-looking statements made in this press release in the context of these risks and uncertainties. The Company disclaims any intent or obligation to update, revise or withdraw any forward-looking statement in this press release, except as required by applicable law or regulation. [1] As of December 31, 2025. Appendix Condensed Consolidated Statements of Operations (Unaudited) (dollars in thousands, except share and per share data) Amounts may not sum due to rounding. Three Months Ended June 30, Six Months Ended June 30, 2026 2025 2026 2025 Revenue—net 7,998 2,108 13,235 21,193 Costs and expenses: Cost of revenue 10,312 1,205 11,424 2,670 Amortization expense 4,185 2,839 8,370 5,678 Research and development expenses—net 367,292 39,667 421,951 75,440 Sales and marketing expenses 29,328 3,413 43,064 6,802 General and administrative expenses 151,907 6,071 160,603 11,569 Total costs and expenses 563,024 53,195 645,412 102,159 Loss from operations (555,026) (51,087) (632,177) (80,966) Interest income—net (4,719) (999) (9,483) (2,343) Loss on change in fair value of warrant liabilities 47,615 6,400 111,815 7,800 Other (income)/expense—net (1,971) 429 (2,013) 800 Loss before taxes (595,951) (56,917) (732,496) (87,223) Tax expense 569 — 617 183 Net loss (596,520) (56,917) (733,113) (87,406) Less: Net loss attributable to Quantinuum (Cayman) prior to the Transactions (110,087) N/A (246,680) N/A Less: Net loss attributable to the non-controlling interest (421,015) N/A (421,015) N/A Net loss attributable to Quantinuum Inc. (65,418) N/A (65,418) N/A Net loss per share attributable to Class A common stockholders—basic and diluted¹ (1.93) N/A (1.93) N/A Weighted-average shares used in computing net loss per share attributable to Class A common stockholders—basic and diluted¹ 33,914,995 N/A 33,914,995 N/A (1) Represents net loss per share of Class A common stock and weighted-average shares of Class A common stock for the period from June 5, 2026 through June 30, 2026, which is the period effective with and following the Transactions as defined in Note 1 — Description of Organization. Refer to Note 14 — Net Earnings Per Share for additional details. Condensed Consolidated Balance Sheets (Unaudited) (dollars in thousands) Amounts may not sum due to rounding. June 30, 2026 December 31, 2025 Assets Current assets: Cash and cash equivalents 2,106,686 762,642 Accounts receivable 3,348 5,068 Due from related parties 532 604 Net investment in lease, current 5,773 5,773 Other current assets 32,357 27,754
Page 5
Total current assets 2,148,696 801,841 Property and equipment—net 150,611 120,965 Right-of-use assets 30,911 10,000 Goodwill 769,631 784,822 Other intangible assets—net 105,105 114,282 Net investment in lease, non-current 7,216 10,102 Prepayment to related parties, non-current 14,136 — Other assets—net 3,665 3,613 Total assets 3,229,971 1,845,625 Liabilities Current liabilities: Accounts payable 29,393 10,620 Due to related parties 52 1,273 Accrued liabilities 109,286 44,358 Total current liabilities 138,731 56,251 Warrant liability — 38,400 License payable, non-current portion 55,345 55,345 Operating lease liabilities, non-current 29,860 7,143 Other liabilities 681 893 Temporary equity Series A convertible redeemable preferred stock, $0.0001 par value per share; 31,983,034 shares authorized as of December 31, 2025; 23,119,001 shares issued and outstanding as of December 31, 2025; liquidation preference of $423,540 as of December 31, 2025 — 288,129 Series A-1 convertible redeemable preferred stock, $0.0001 par value per share; 28,016,966 shares authorized, issued and outstanding as of December 31, 2025; liquidation preference of $479,930,628 as of December 31, 2025 — 400,978 Series B convertible redeemable preferred stock, $0.0001 par value per share; 31,753,266 shares authorized as of December 31, 2025; 31,336,698 shares issued and outstanding as of December 31, 2025; liquidation preference $878,367,645 as of December 31, 2025 — 824,834 Shareholders' equity / Quantinuum (Cayman) equity Quantinuum (Cayman) equity — 173,652 Preferred stock, $0.0001 par value per share; 20,000,000 shares authorized, as of June 30, 2026; no shares issued and outstanding as of June 30, 2026 — — Class A common stock, $0.0001 par value per share; 2,000,000,000 shares authorized as of June 30, 2026; 36,134,196 shares issued and outstanding as of June 30, 2026 3 — Class B common stock, $0.0001 par value per share; 2,000,000,000 shares authorized as of June 30, 2026; 226,771,877 shares issued and outstanding as of June 30, 2026 23 — Additional paid-in-capital 480,105 — Accumulated other comprehensive (loss) income (1,631) — Accumulated deficit (65,418) — Total equity attributable to Quantinuum Inc. / Quantinuum (Cayman) 413,082 173,652 Non-controlling interest 2,592,272 — Total equity 3,005,354 173,652 Total liabilities and equity 3,229,971 1,845,625 Condensed Consolidated Statements of Cash Flows (Unaudited) (dollars in thousands) Amounts may not sum due to rounding. Six Months Ended June 30, 2026 2025 Cash flows from operating activities: Net loss (733,113) (87,406) Adjustments to reconcile to net cash used for operating activities Depreciation and amortization 18,460 14,851 Noncash lease expense 230 1,395 Sales under sales-type lease — (16,526) Stock compensation expense 447,454 — Loss on change in fair value of warrant liabilities 111,815 7,800 (Gain)/Loss on disposal and write down of assets (10) 901
Page 6
Interest expense 4 4 Foreign exchange (gain)/loss—net 62 (15) Access to quantum computing hardware 4,648 2,991 Changes in operating assets and liabilities Accounts receivable 1,690 1,843 Due from related parties 38 229 Other current assets (11,082) 565 Net investment in leases 2,886 2,886 Prepayment to related parties, non-current (14,136) — Other assets—net 472 1,516 Accounts payable 15,463 4,387 Due to related parties (710) (534) Accrued liabilities 26,943 (746) Other liabilities (199) 79 Net cash used for operating activities (129,085) (65,780) Cash flows from investing activities: Capital expenditures (39,177) (37,721) Net cash used for investing activities (39,177) (37,721) Cash flows from financing activities: Proceeds from issuance of common stock 1,628,774 — Common stock issuance costs (23,534) — Withholding taxes paid on stock compensation (91,984) — Net cash provided by financing activities 1,513,256 — Effect of exchange rate changes on cash and cash equivalents (951) 23 Net increase (decrease) in cash and cash equivalents 1,344,044 (103,478) Cash and cash equivalents at beginning of period 762,642 172,343 Cash and cash equivalents at end of period 2,106,686 68,865 Non-cash investing and financing activities: Unpaid purchases of property and equipment 9,227 8,348 Unpaid withholding taxes on stock compensation 38,692 — Unpaid issuance costs 5,672 — Value of shares issued via cashless warrant exercise 150,215 — Reconciliation of GAAP Gross Profit to Adjusted Gross Profit (Unaudited) (dollars in thousands, except percentages) Amounts may not sum due to rounding. Three Months Ended June 30, Six Months Ended June 30, 2026 2025 2026 2025 Revenue, net 7,998 2,108 13,235 21,193 Cost of revenue 10,312 1,205 11,424 2,670 Amortization of acquired intangibles, cost of revenue portion¹ 2,839 2,839 5,679 5,679 GAAP gross profit (5,153) (1,936) (3,868) 12,844 GAAP gross margin (64.4 %) (91.8 %) (29.2 %) 60.6 % Add back: Equity compensation and related employer taxes² 6,573 — 6,573 — Add back: Depreciation and amortization³ 3,515 3,249 7,039 6,579 Adjusted gross profit 4,935 1,312 9,744 19,423 Adjusted gross margin 61.7 % 62.3 % 73.6 % 91.6 % (1) Our condensed consolidated statements of operations present amortization of acquired intangibles as a single separate line and do not present a gross profit subtotal. The amount shown in this table is the portion of that line attributable to cost of revenue, allocated according to the assets to which it relates. Cost of revenue is presented as reported. The remaining portion is presented within research and development. (2) Represents stock-based compensation expense and the related employer payroll taxes on equity vesting, in each case attributable to cost of revenue. Employer payroll taxes were 242 and 242 for the three and six months ended June 30, 2026,
Page 7
respectively, and 0 in the corresponding prior year periods. These amounts are a subset of the equity compensation and related employer taxes adjustment presented in the reconciliation of GAAP net loss. (3) Represents depreciation of property and equipment and amortization of acquired intangible assets attributable to cost of revenue. Reconciliation of GAAP Net Loss to Adjusted Net Loss, Adjusted EBITDA and Adjusted Earnings Per Share (Unaudited) (dollars in thousands, except share and per share amounts) Amounts may not sum due to rounding. Three Months Ended June 30, Six Months Ended June 30, 2026 2025 2026 2025 Numerator Net loss attributable to Quantinuum Inc. (65,418) N/A (65,418) N/A Less: Net loss attributable to Quantinuum (Cayman) prior to the Transactions (110,087) N/A (246,680) N/A Less: Net loss attributable to the non-controlling interest (421,015) N/A (421,015) N/A GAAP net loss, as-converted¹ (596,520) (56,917) (733,113) (87,406) Add back: income tax expense 569 — 617 183 Equity compensation and related employer taxes² 464,587 — 464,587 — IPO readiness, legal and other transaction costs³ 10,620 — 19,801 — Warrant fair value adjustment⁴ 47,615 6,400 111,815 7,800 Loss on disposal and write down of assets 24 594 (10) 901 Adjusted pre-tax loss, fully distributed (73,105) (49,923) (136,303) (78,522) Tax at assumed statutory rate⁵ 0 0 0 0 Adjusted net loss, fully distributed (73,105) (49,923) (136,303) (78,522) Interest income, net (4,719) (999) (9,483) (2,343) Depreciation and other⁶ 5,329 4,630 10,090 9,173 Amortization of acquired intangibles⁷ 4,185 2,839 8,370 5,678 Adjusted EBITDA (68,310) (43,453) (127,326) (66,014) Denominator⁸ Weighted-average Class A common shares outstanding, basic and diluted 33,914,995 N/A 33,914,995 N/A Add: Common Units of Quantinuum Holdings 227,582,892 N/A 227,582,892 N/A Adjusted shares, fully distributed, basic and diluted 261,497,887 N/A 261,497,887 N/A Per share⁸ GAAP net loss per Class A common share, basic and diluted (1.93) N/A (1.93) N/A Adjusted net loss per share, fully distributed, basic and diluted (0.28) n.m. (0.52) n.m. (1) The as-converted basis includes the economic interests represented by Class A common stock and Common Units of Quantinuum Holdings as if all Common Units were exchanged for Class A common stock. It is used because Class A common stock represents a minority of the economic interest in Quantinuum Holdings. (2) Represents non-cash compensation expense associated with equity-based awards, including expense recognized in connection with the Reorganization, together with the related employer payroll taxes on equity vesting. Employer payroll taxes were $17,127 and $17,127 for the three and six months ended June 30, 2026, respectively, and zero in the corresponding prior year periods. The stock-based compensation component agrees to the stock compensation expense line in the condensed consolidated statements of cash flows. (3) Represents costs of the initial public offering, transaction costs, and the transition to public company reporting. These costs represent professional fees for advisory, legal, accounting, valuation and other professional or consulting services incurred related to the IPO. These costs are scoped by reference to their cause and have a defined end. They do not include the ongoing costs of operating as a public company. (4) Represents the non-cash change in fair value of liability-classified warrants, which is driven by valuation inputs and accounting remeasurement rather than operating activity. (5) Represents the tax effect of the adjusted pre-tax loss using the assumed statutory tax rate presented in the table. (6) Represents total depreciation and amortization per our condensed consolidated statements of cash flows, less amortization of acquired intangibles shown separately below. Includes amortization of capitalized software. (7) Represents total amortization of acquired intangible assets for the period and agrees to the amortization expense line in the condensed consolidated statements of operations. (8) The denominator comprises Class A common stock and all Common Units of Quantinuum Holdings. Class B common stock is non-economic, carries voting rights only, and is cancelled upon exchange of the corresponding Common Units. (9) GAAP net loss per Class A common share covers only the period from June 5, 2026, following the Transactions, while adjusted net loss per share, fully distributed, covers the full period presented. The two measures therefore are not calculated on the same period basis. No per share amounts are presented for periods prior to the Reorganization because the calculation would not produce values meaningful to users.
Page 8
View original content to download multimedia: https://www.prnewswire.com/news-releases/quantinuum-reports-second-quarter- 2026-results-302848859.html SOURCE Quantinuum Contacts - Investor & Media Contact: Shub Mukherjee - Investor Contact - investors@quantinuum.com; Aaron Sorenson - Media Contact - press@quantinuum.com